52
Views
3
CrossRef citations to date
0
Altmetric
PREGNANCY

Validation of disease registration in pregnant women in the Medical Birth Registry of Norway

, , , &
Pages 1083-1089 | Received 12 Jan 2009, Published online: 19 Sep 2009

References

  • Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, et al. The teratogenicity zof anticonvulsant drugs. N Engl J Med. 2001; 344: 1132–8
  • Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006; 333: 171–180
  • Egeland GM, Skjærven R, Irgens LM. Birth characteristics of women who develop gestational diabetes: population based study. BMJ. 2000; 321: 546–7
  • Egeland GM, Skjærven R, Irgens LM. The reproductive health of daughters of pregestational diabetic women: Medical Birth Registry of Norway. Paediatr Perinat Epidemiol. 2002; 16: 290–6
  • King PB, Lie RT, Irgens LM. Spina bifida and cleft lip among newborns of Norwegian women with epilepsy: changes related to the use of anticonvulsants. Am J Public Health. 1996; 86: 1454–6
  • Øyen N, Vollset SE, Eide MG, Bjerkedal T, Skjærven R. Maternal epilepsy and offsprings’ adult intelligence: a population-based study from Norway. Epilepsia. 2007; 48: 1731–8
  • Rasmussen S, Irgens LM. History of fetal growth restriction is more strongly associated with severe rather than milder pregnancy-induced hypertension. Hypertension. 2008; 51: 1231–8
  • Stene LC, Eidem I, Vangen S, Joner G, Irgens LM, Moe N. The validity of the diabetes mellitus diagnosis in the Medical Birth Registry of Norway. Nor J Epidemiol. 2007; 17: 165–74
  • Hawthorne G, Irgens LM, Lie RT. Outcome of pregnancy in diabetic women in northeast England and in Norway, 1994–7. BMJ. 2000; 321: 730–1
  • Hawthorne G, Irgens LM, Lie RT, Moe N, Jervell J. Retraction of paper on maternal diabetes. BMJ. 2003; 327: 929
  • Aamodt G, Stene LC, Njølstad PR, Søvik O, Joner G. Spatiotemporal trends and age-period-cohort modeling of the incidence of type 1 diabetes among children aged <15 years in Norway 1973–1982 and 1989–2003. Diabetes Care 2007; 30: 884–9
  • Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol. 2007; 14: 38–43
  • Skomsvoll JF, Østensen M, Baste V, Irgens LM. Validity of a rheumatic disease diagnosis in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand. 2002; 81: 831–4
  • Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004–06. Br J Clin Pharmacol. 2008; 69: 653–60
  • Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) – new opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol. 2008; 18: 129–36
  • Hågå A, Sverre J. Pricing and reimbursement of pharmaceuticals in Norway. Eur J Health Econ. 2002; 3: 215–20
  • WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs 2007. OsloNorway: WHO Collaborating Centre for Drug Statistics Methodology; 2006.
  • Irgens LM. The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand. 2000; 79: 435–9
  • Glueck CJ, Goldenberg N, Sieve L, Wang P. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet. Metabolism. 2008; 57: 954–60
  • Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2008. Available online at: http://www.ginasthma.org, , (Assessed April 15, 2009).
  • Vollset SE. Confidence intervals for a binomial proportion. Stat Med. 1993; 12: 809–24
  • Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ. 1993; 307: 846–8
  • Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.